ALZpath signs licensing deal with Abbott to develop Alzheimer's blood test

By Sahil Pandey June 24 (Reuters) - ALZpath said on Wednesday it had signed a global licensing agreement with Abbott ...
Fierce Biotech

Abbott pens blood-based Alzheimer's testing pact with ALZpath

Abbott has become the latest company to team up with Alzheimer’s disease blood test developer ALZpath. | Abbott has become ...

ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing

ALZpath Inc., the leader in blood test-based diagnostic solutions for Alzheimer's disease, today announced a licensing agreement with Abbott (NYSE: ABT), a global healthcare leader, to incorporate ...